U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Anisocoria

MedGen UID:
1944
Concept ID:
C0003079
Finding
Synonyms: Inequality, Pupillary Size; Pupil Diameter Unequal; Pupillary Size Inequality
SNOMED CT: Anisocoria (13045009); Unequal pupils (13045009); Anisocoria - unequal pupil diameter (13045009); Unequal pupil diameter (13045009)
 
HPO: HP:0009916
Monarch Initiative: MONDO:0007122
OMIM®: 106240

Definition

Anisocoria, or unequal pupil size, may represent a benign physiologic variant or a manifestation of disease. [from HPO]

Term Hierarchy

Conditions with this feature

Pseudoexfoliation glaucoma
MedGen UID:
60133
Concept ID:
C0206368
Disease or Syndrome
Exfoliation syndrome (XFS) is a common age-related disorder of the extracellular matrix that is frequently associated with severe chronic secondary open-angle glaucoma and cataract. XFS syndrome may affect up to 30% of people over 60 years of age worldwide and is biomicroscopically diagnosed by abnormal microfibrillar deposits on ocular structures that line the aqueous-bathed surfaces of the anterior segment (summary by Schlotzer-Schrehardt and Naumann, 2006).
Glucocorticoid deficiency with achalasia
MedGen UID:
82889
Concept ID:
C0271742
Disease or Syndrome
Triple A syndrome is an inherited condition characterized by three specific features: achalasia, Addison disease, and alacrima. Achalasia is a disorder that affects the ability to move food through the esophagus, the tube that carries food from the throat to the stomach. It can lead to severe feeding difficulties and low blood glucose (hypoglycemia). Addison disease, also known as primary adrenal insufficiency, is caused by abnormal function of the small hormone-producing glands on top of each kidney (adrenal glands). The main features of Addison disease include fatigue, loss of appetite, weight loss, low blood pressure, and darkening of the skin. The third major feature of triple A syndrome is a reduced or absent ability to secrete tears (alacrima). Most people with triple A syndrome have all three of these features, although some have only two.\n\nMany of the features of triple A syndrome are caused by dysfunction of the autonomic nervous system. This part of the nervous system controls involuntary body processes such as digestion, blood pressure, and body temperature. People with triple A syndrome often experience abnormal sweating, difficulty regulating blood pressure, unequal pupil size (anisocoria), and other signs and symptoms of autonomic nervous system dysfunction (dysautonomia).\n\nPeople with this condition may have other neurological abnormalities, such as developmental delay, intellectual disability, speech problems (dysarthria), and a small head size (microcephaly). In addition, affected individuals commonly experience muscle weakness, movement problems, and nerve abnormalities in their extremities (peripheral neuropathy). Some develop optic atrophy, which is the degeneration (atrophy) of the nerves that carry information from the eyes to the brain. Many of the neurological symptoms of triple A syndrome worsen over time.\n\nPeople with triple A syndrome frequently develop a thickening of the outer layer of skin (hyperkeratosis) on the palms of their hands and the soles of their feet. Other skin abnormalities may also be present in people with this condition.\n\nAlacrima is usually the first noticeable sign of triple A syndrome, as it becomes apparent early in life that affected children produce little or no tears while crying. They develop Addison disease and achalasia during childhood or adolescence, and most of the neurologic features of triple A syndrome begin during adulthood. The signs and symptoms of this condition vary among affected individuals, even among members of the same family.
Facial spasm
MedGen UID:
124458
Concept ID:
C0278151
Finding
Sudden, repetitive, nonrhythmic motor movements (spasms), involving the eyes and muscles of the face.
Ophthalmoplegia, familial static
MedGen UID:
371666
Concept ID:
C1833839
Disease or Syndrome
Scalp-ear-nipple syndrome
MedGen UID:
357183
Concept ID:
C1867020
Disease or Syndrome
Scalp-ear-nipple syndrome is characterized by aplasia cutis congenita of the scalp, breast anomalies that range from hypothelia or athelia to amastia, and minor anomalies of the external ears. Less frequent clinical characteristics include nail dystrophy, dental anomalies, cutaneous syndactyly of the digits, and renal malformations. Penetrance appears to be high, although there is substantial variable expressivity within families (Marneros et al., 2013).
Nephronophthisis 11
MedGen UID:
462146
Concept ID:
C3150796
Disease or Syndrome
The nephronophthisis (NPH) phenotype is characterized by reduced renal concentrating ability, chronic tubulointerstitial nephritis, cystic renal disease, and progression to end-stage renal disease (ESRD) before age 30 years. Three age-based clinical subtypes are recognized: infantile, juvenile, and adolescent/adult. Infantile NPH can present in utero with oligohydramnios sequence (limb contractures, pulmonary hypoplasia, and facial dysmorphisms) or postnatally with renal manifestations that progress to ESRD before age 3 years. Juvenile NPH, the most prevalent subtype, typically presents with polydipsia and polyuria, growth retardation, chronic iron-resistant anemia, or other findings related to chronic kidney disease (CKD). Hypertension is typically absent due to salt wasting. ESRD develops at a median age of 13 years. Ultrasound findings are increased echogenicity, reduced corticomedullary differentiation, and renal cysts (in 50% of affected individuals). Histologic findings include tubulointerstitial fibrosis, thickened and disrupted tubular basement membrane, sporadic corticomedullary cysts, and normal or reduced kidney size. Adolescent/adult NPH is clinically similar to juvenile NPH, but ESRD develops at a median age of 19 years. Within a subtype, inter- and intrafamilial variability in rate of progression to ESRD is considerable. Approximately 80%-90% of individuals with the NPH phenotype have no extrarenal features (i.e., they have isolated NPH); ~10%-20% have extrarenal manifestations that constitute a recognizable syndrome (e.g., Joubert syndrome, Bardet-Biedl syndrome, Jeune syndrome and related skeletal disorders, Meckel-Gruber syndrome, Senior-Løken syndrome, Leber congenital amaurosis, COACH syndrome, and oculomotor apraxia, Cogan type).
Syndromic X-linked intellectual disability 17
MedGen UID:
477091
Concept ID:
C3275460
Mental or Behavioral Dysfunction
Intellectual disability-alacrima-achalasia syndrome is a rare, genetic intellectual disability syndrome characterized by delayed motor and cognitive development, absence or severe delay in speech development, intellectual disability, and alacrima. Achalasia/dysphagia and mild autonomic dysfunction (i.e. anisocoria) have also been reported in some patients. The phenotype is similar to the one observed in autosomal recessive Triple A syndrome, but differs by the presence of intellectual disability in all affected individuals.
SIN3A-related intellectual disability syndrome due to a point mutation
MedGen UID:
934771
Concept ID:
C4310804
Disease or Syndrome
Witteveen-Kolk syndrome (WITKOS) is an autosomal dominant disorder with characteristic distinctive facial features, microcephaly, short stature, and mildly impaired intellectual development with delayed cognitive and motor development and subtle anomalies on MRI-brain imaging (summary by Balasubramanian et al., 2021).
Alacrima, achalasia, and intellectual disability syndrome
MedGen UID:
1640947
Concept ID:
C4706563
Disease or Syndrome
Alacrima, achalasia, and impaired intellectual development syndrome (AAMR) is an autosomal recessive disorder characterized by onset of these 3 main features at birth or in early infancy. More variable features include hypotonia, gait abnormalities, anisocoria, and visual or hearing deficits. The disorder shows similarity to the triple A syndrome (231550), but patients with AAMR do not have adrenal insufficiency (summary by Koehler et al., 2013). See also 300858 for a phenotypically similar disorder that shows X-linked inheritance.
Intellectual developmental disorder with impaired language and dysmorphic facies
MedGen UID:
1684804
Concept ID:
C5231444
Disease or Syndrome
Intellectual developmental disorder with impaired language and dysmorphic facies (IDDILF) is an autosomal dominant disorder characterized by global developmental delay apparent from infancy, impaired language development, and dysmorphic facial features, including hypertelorism, epicanthal folds, and abnormal palpebral fissures. Some patients may have additional findings, including feeding difficulties, mild cardiac or genitourinary defects, and distal skeletal anomalies (summary by Balak et al., 2019).
Chromosome 16q12 duplication syndrome
MedGen UID:
1794292
Concept ID:
C5562082
Disease or Syndrome
Chromosome 16q12 duplication syndrome is characterized by early-onset progressive cone dystrophy, with early blue cone involvement. Patients report reduced visual acuity in the first decade of life, as well as difficulty differentiating colors, photophobia, and reduced night vision (Kohl et al., 2021). Tritanopia can also be caused by heterozygous mutation in the OPN1SW gene (613522) on chromosome 7q32 (see 190900).

Professional guidelines

PubMed

Mierzwiński J, Wrukowska I, Tyra J, Paczkowski D, Szcześniak T, Haber K
Int J Pediatr Otorhinolaryngol 2018 Nov;114:9-14. Epub 2018 Aug 23 doi: 10.1016/j.ijporl.2018.08.021. PMID: 30262374
Prasad S
Am J Med 2018 Feb;131(2):120-128. Epub 2017 Oct 24 doi: 10.1016/j.amjmed.2017.10.008. PMID: 29079403
Multack RF, Lannin WC, Olbum JR
J Am Osteopath Assoc 1989 Jul;89(7):917-24. PMID: 2670854

Recent clinical studies

Etiology

Blum ASS, Riggins NY, Hersey DP, Atwood GS, Littenberg B
J Neurol 2023 Jun;270(6):2938-2949. Epub 2023 Mar 7 doi: 10.1007/s00415-023-11609-1. PMID: 36882660
Prescott BR, Saglam H, Duskin JA, Miller MI, Thakur AS, Gholap EA, Hutch MR, Smirnakis SM, Zafar SF, Dupuis J, Benjamin EJ, Greer DM, Ong CJ
Crit Care Med 2022 Feb 1;50(2):e143-e153. doi: 10.1097/CCM.0000000000005272. PMID: 34637415Free PMC Article
Vargas D, Castro C
Arq Bras Oftalmol 2018 Jun;81(3):195-201. doi: 10.5935/0004-2749.20180041. PMID: 29924199
Chesnut RM, Temkin N, Dikmen S, Rondina C, Videtta W, Petroni G, Lujan S, Alanis V, Falcao A, de la Fuenta G, Gonzalez L, Jibaja M, Lavarden A, Sandi F, Mérida R, Romero R, Pridgeon J, Barber J, Machamer J, Chaddock K
J Neurotrauma 2018 Jan 1;35(1):54-63. Epub 2017 Sep 26 doi: 10.1089/neu.2016.4472. PMID: 28726590Free PMC Article
Bullock MR, Chesnut R, Ghajar J, Gordon D, Hartl R, Newell DW, Servadei F, Walters BC, Wilberger JE; Surgical Management of Traumatic Brain Injury Author Group
Neurosurgery 2006 Mar;58(3 Suppl):S7-15; discussion Si-iv. PMID: 16710967

Diagnosis

Cherayil NR, Tamhankar MA
Med Clin North Am 2021 May;105(3):511-529. doi: 10.1016/j.mcna.2021.01.005. PMID: 33926644
Falardeau J
Int Ophthalmol Clin 2019 Summer;59(3):125-139. doi: 10.1097/IIO.0000000000000276. PMID: 31233420
Martin TJ
ACS Chem Neurosci 2018 Feb 21;9(2):177-186. Epub 2017 Dec 20 doi: 10.1021/acschemneuro.7b00405. PMID: 29260849
Gross JR, McClelland CM, Lee MS
Curr Opin Ophthalmol 2016 Nov;27(6):486-492. doi: 10.1097/ICU.0000000000000316. PMID: 27585208
Egan RA, LaFrance WC Jr
Semin Neurol 2015 Oct;35(5):557-63. Epub 2015 Oct 6 doi: 10.1055/s-0035-1563580. PMID: 26444401

Therapy

Jakobsen EW, Nersesjan V, Albrechtsen SS, Othman MH, Amiri M, Knudsen NV, Larson MD, Hassager C, Møller K, Kjaergaard J, Kondziella D
Acta Neurochir (Wien) 2023 Jun;165(6):1483-1494. Epub 2023 Apr 4 doi: 10.1007/s00701-023-05569-8. PMID: 37014450Free PMC Article
Vargas D, Castro C
Arq Bras Oftalmol 2018 Jun;81(3):195-201. doi: 10.5935/0004-2749.20180041. PMID: 29924199
Harer K, Alverson B
Hosp Pediatr 2018 May;8(5):300-301. Epub 2018 Apr 12 doi: 10.1542/hpeds.2017-0204. PMID: 29650677
Chesnut RM, Temkin N, Dikmen S, Rondina C, Videtta W, Petroni G, Lujan S, Alanis V, Falcao A, de la Fuenta G, Gonzalez L, Jibaja M, Lavarden A, Sandi F, Mérida R, Romero R, Pridgeon J, Barber J, Machamer J, Chaddock K
J Neurotrauma 2018 Jan 1;35(1):54-63. Epub 2017 Sep 26 doi: 10.1089/neu.2016.4472. PMID: 28726590Free PMC Article
Geller DE
J Aerosol Med 2007;20 Suppl 1:S100-8; discussion S109. doi: 10.1089/jam.2007.0585. PMID: 17411401

Prognosis

Jakobsen EW, Nersesjan V, Albrechtsen SS, Othman MH, Amiri M, Knudsen NV, Larson MD, Hassager C, Møller K, Kjaergaard J, Kondziella D
Acta Neurochir (Wien) 2023 Jun;165(6):1483-1494. Epub 2023 Apr 4 doi: 10.1007/s00701-023-05569-8. PMID: 37014450Free PMC Article
Prescott BR, Saglam H, Duskin JA, Miller MI, Thakur AS, Gholap EA, Hutch MR, Smirnakis SM, Zafar SF, Dupuis J, Benjamin EJ, Greer DM, Ong CJ
Crit Care Med 2022 Feb 1;50(2):e143-e153. doi: 10.1097/CCM.0000000000005272. PMID: 34637415Free PMC Article
George AS, Abraham AP, Nair S, Joseph M
Neurol India 2019 Nov-Dec;67(6):1500-1503. doi: 10.4103/0028-3886.273623. PMID: 31857545
Martin TJ
ACS Chem Neurosci 2018 Feb 21;9(2):177-186. Epub 2017 Dec 20 doi: 10.1021/acschemneuro.7b00405. PMID: 29260849
De Smit E, O'Sullivan E, Mackey DA, Hewitt AW
Graefes Arch Clin Exp Ophthalmol 2016 Dec;254(12):2291-2306. Epub 2016 Aug 5 doi: 10.1007/s00417-016-3434-7. PMID: 27495301

Clinical prediction guides

Blum ASS, Riggins NY, Hersey DP, Atwood GS, Littenberg B
J Neurol 2023 Jun;270(6):2938-2949. Epub 2023 Mar 7 doi: 10.1007/s00415-023-11609-1. PMID: 36882660
George AS, Abraham AP, Nair S, Joseph M
Neurol India 2019 Nov-Dec;67(6):1500-1503. doi: 10.4103/0028-3886.273623. PMID: 31857545
Chesnut RM, Temkin N, Dikmen S, Rondina C, Videtta W, Petroni G, Lujan S, Alanis V, Falcao A, de la Fuenta G, Gonzalez L, Jibaja M, Lavarden A, Sandi F, Mérida R, Romero R, Pridgeon J, Barber J, Machamer J, Chaddock K
J Neurotrauma 2018 Jan 1;35(1):54-63. Epub 2017 Sep 26 doi: 10.1089/neu.2016.4472. PMID: 28726590Free PMC Article
De Smit E, O'Sullivan E, Mackey DA, Hewitt AW
Graefes Arch Clin Exp Ophthalmol 2016 Dec;254(12):2291-2306. Epub 2016 Aug 5 doi: 10.1007/s00417-016-3434-7. PMID: 27495301
Bullock MR, Chesnut R, Ghajar J, Gordon D, Hartl R, Newell DW, Servadei F, Walters BC, Wilberger JE; Surgical Management of Traumatic Brain Injury Author Group
Neurosurgery 2006 Mar;58(3 Suppl):S7-15; discussion Si-iv. PMID: 16710967

Recent systematic reviews

Merdler-Rabinowicz R, Prat D, Pode-Shakked B, Abel G, Chorin O, Somech R, Raas-Rothschild A
Eur J Med Genet 2021 Jun;64(6):104210. Epub 2021 Mar 30 doi: 10.1016/j.ejmg.2021.104210. PMID: 33794347
Alamanos C, Raab P, Gamulescu A, Behr M
Oral Surg Oral Med Oral Pathol Oral Radiol 2016 Mar;121(3):e39-50. Epub 2015 Nov 10 doi: 10.1016/j.oooo.2015.10.023. PMID: 26768073
Narayana S, McGee S
Am J Med 2015 Nov;128(11):1220-1224.e1. Epub 2015 Jul 11 doi: 10.1016/j.amjmed.2015.06.026. PMID: 26169885

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...